Applied Chemistry for Engineering (공업화학)

The Korean Society of Industrial and Engineering Chemistry (한국공업화학회)
권호 표지

Transdermal Drug Delivery System

경피 흡수와 연구동향

  • 진화은 (연세대학교 연세나노과학기술연구단) ;
  • 김중현 (연세대학교 화학공학과) ;
  • 백일영 (연세대학교 체육교육학과)
  • Received : 2004.08.24
  • Accepted : 2004.10.11
  • Published : 2005.02.10
Download PDF
⟨ Previous Next ⟩

Abstract

Many scientists have been interested in drug delivery system (DDS) which improves medical treatment for curing a disease. Transdermal drug delivery (TDD) that is one of the DDS offers several advantages over the traditional methods. For this reason, the study of TDD has been investigated in various field. In this paper, principle of transdermal delivery and penetration enhancers into the skin including in vitro and in vivo data have been studied.

최근 약물전달시스템에 관심이 높아지면서 질병 치료를 목적으로 치료용 약물들이 많이 개발되기 시작하였으며, 이 중 경피흡수제제는 여러 가지 이점으로 인하여 지속적으로 연구를 진행하고 있는 흥미로운 분야이다. 본 고에서는 이러한 경피흡수의 원리 및 흡수를 촉진하는 물질들에 대하여 서술하였으며, 이를 발전시키기 위한 in vitro 및 in vivo 연구에 대하여 논하였다.

Keywords

References

  1. H. C. Ansel, N. G. Popovich, and L. V. Allen, Pharmaceutical Dosage Forms and Drug Delivery Systems, 357, Williams and Wilkins, Malvern (1995)
  2. A. C. Williams and B. W. Barry, Critical Reviews in Therapeutic Drug Carrier Systems, 9, 305 (1992)
  3. K. Moser, K. Kriwet, A. Naik, Y. N. Kalia, and R. H. Guy, European J. Pharmaceutics and Biopharmaceutics and Biopharmaceutics, 52, 103 (2001) https://doi.org/10.1016/S0939-6411(01)00166-7
  4. E. J. Wood and P. T. Bladon, The Human Skin: Studies in Biology Series, 164, Edward Arnold, London (1985)
  5. R. M. Marks, S. P. Barton, and C. Edwards, The physical Nature of the Skin, MTP Press Ltd., Lancaster (1988)
  6. J. A. Bouwstra and P. L. Honeywell-Nguyen, Advanced Drug Delivery Review, 54, S41 (2002) https://doi.org/10.1016/S0169-409X(02)00114-X
  7. G. L. Wilkes, I. A. Brown, and R. H. Widnauer, Critical Review of Bioengineering, 1, 453 (1973)
  8. M. A. Lampe, A. L. Burligame, J. Whitney, M. L. Williams, B. E. Brown, E. Roitman, and P. M. Elias, J. Lipid Research, 24, 120 (1983)
  9. P. M. Elias, International J. Dermatology, 20, 1 (1981) https://doi.org/10.1111/j.1365-4362.1981.tb05278.x
  10. P. W. Wertz, K. C. Madison, and Downing, D. T. Investigative Dermatology, 92, 109 (1989) https://doi.org/10.1111/1523-1747.ep13071317
  11. P. M. Elias and D. S. Friend, Journal of Cell Biology, 65, 180 (1975) https://doi.org/10.1083/jcb.65.1.180
  12. S. Grayson and P. M. Elias, J. Investigative Dermatology, 78, 128 (1982) https://doi.org/10.1111/1523-1747.ep12505953
  13. M. L. Williams and P. M. Elias, Critical Reviews in Therapeutic Drug Carrier Systems, 3, 95 (1987)
  14. K. Knutson, R. O. Potts, D. B. Guzek, G. M. Golden, J. E. McKie, W. J. Lambert, and W. I. Higuchi, Macro- and Molecular Physical-Chemical Considerations in Understanding Drug Transport in the Stratum Corneum, In Advances in Drug Delivery Systems, eds. J. M. Anderson, and S. W. Kimeds, 1, 67, Elsevier, Amsterdam (1986)
  15. R. L. Potts, Physical Characterization of the Stratum Corneum: the Relationship of Mechanical and Barrier Properties to Lipid and Protein Structure, Transdermal Drug Delivery; Developmental Issues and Research Initiatives, eds. J. Hadgraft, and R. H. Guy, Ch. 2, Marcel Dekker, New York (1989)
  16. S. H. White, D. Mirejovsky, and G. I. King, Biochemistry, 27, 3725 (1988) https://doi.org/10.1021/bi00410a031
  17. B. W. Barry, The LPP Theory of Skin Penetration, in In Vitro Percutaneous Absorption: Principles, Fundamentals and Applications, eds. R. L. Bronaugh, and H. I. Maibach, 165, CRC Pres. Boca Raton (1991)
  18. J. D. Bos and M. M. Meinardi, Experimental Dermatology, 9, 165 (2000) https://doi.org/10.1034/j.1600-0625.2000.009003165.x
  19. P. W. Wertz and D. T. Downing, Transdermal Drug Delivery: Developmental Issues and Research Initiatives, eds. J. Hadgraft, and R. H. Guy, 1, Marcel Dekker, New York, Basel, Hong Kong (1989)
  20. R. H. Guy, Pharmacological Research, 13, 1765 (1996) https://doi.org/10.1023/A:1016060403438
  21. P. Karande, A. Jain, and S. Mitragotri, Nature Biotechnology, 22, 192 (2004) https://doi.org/10.1038/nbt928
  22. R. H. Guy, Y. N. Kalia, M. B. Delgado-Charro, V. Merino, A. Lopez, and D. Marro, Journal of Controlled Release, 64, 129 (2000) https://doi.org/10.1016/S0168-3659(99)00132-7
  23. S. Mitragotri, D. Blankschtein, and R. Langer, Science, 269, 850 (1995) https://doi.org/10.1126/science.7638603
  24. B. C. Finnin and T. M. Morgan, J. Pharmaceutical Science, 88, 955 (1999) https://doi.org/10.1021/js990154g
  25. E. French, C. Potton, and K. Walters, Pharmaceutical Skin Penetration Enhancement, eds. K. Walters, and J. Hadgraft, 113, Marcel Dekker, New York (1993)
  26. N. Kanikkannan, K. Kanimalla, S. S. Lamba, and M. Singh, Current Medical Chemistry, 7, 593 (2000) https://doi.org/10.2174/0929867003374840
  27. U. T. Lashmar, J. Hdgraft, and N. Thomas, J. Pharmacy and Pharmacology, 41, 118 (1989) https://doi.org/10.1111/j.2042-7158.1989.tb06405.x
  28. M. Suhonen, J. Bouwstra, and A. Urtti, J. Controlled Release, 59, 149 (1999) https://doi.org/10.1016/S0168-3659(98)00187-4
  29. S. Mitragotri, Pharmacological Research, 18, 1022 (2001)
  30. M. K. Robinson and M. A. Perkins, American J. Contact Dermatitis, 13, 19 (2002) https://doi.org/10.1053/ajcd.2002.29952
  31. A. C. Williams and B. W. Barry, Advanced Drug Delivery Reviews, 56, 603 (2004) https://doi.org/10.1016/j.addr.2003.10.025
  32. A. M. Kligman, JAMA, 193, 796 (1965) https://doi.org/10.1001/jama.1965.03090100042010
  33. D. Southwell and B. W. Barry, J. Investigative Dermatology, 80, 507 (1983) https://doi.org/10.1111/1523-1747.ep12535090
  34. E. S. Park, S. J. Chang, Y. S. Rhee, and S. C. Chi, Drug Development and Industrial Pharmacy, 27, 975 (2001) https://doi.org/10.1081/DDC-100107679
  35. R. Aboofazeli, H. Zia, and T. E. Needham, Drug Delivery, 9, 239 (2002) https://doi.org/10.1080/10717540260397855
  36. S. Santoyo and P. Ygartua, European J. Pharmaceutical Biopharmacetics, 50, 245 (2000) https://doi.org/10.1016/S0939-6411(00)00097-7
  37. M. Goodman and B. W. Barry, International J. Pharmacology, 57, 29 (1989) https://doi.org/10.1016/0378-5173(89)90260-3
  38. B. Berner, G. C. Mazzenga, J. H. Otte, R. J. Steffens, R. H. Juang, and C. D. Ebert, J. Pharmacological Sciences, 78, 402 (1989) https://doi.org/10.1002/jps.2600780512
  39. T. Kurihara-Bergstrom, K. Knutson, L. J. De Noble, and C. Y. Goates, Pharmacological Research, 7, 762 (1990) https://doi.org/10.1023/A:1015879925147
  40. R. A. Tupker, J. Pinnagoda, and J. P. Nater, Acta DermatoVenereologica, 70, 1 (1900)
  41. T. J. Franz, J. Investigative Dermatology, 64, 190 (1975) https://doi.org/10.1111/1523-1747.ep12533356
  42. H. I. Maibach, Animal Models in Dermatology, Churchill- Livingstone, Edinburgh (1975)
  43. J. H. W. Mali, Current Problems in Dermatology, 7, Karger, Basel ( 1978)
  44. R. L. Bronaugh, R. F. Stewart, E. R. Congdon, and A. L. Giles, Applied Pharmacology, 62, 481 (1982) https://doi.org/10.1016/0041-008X(82)90149-1
  45. B. W. Barry, Dermatological Formulations: Percutaneous Absorption. Drugs and the Pharmaceutical Sciences, 18, Marcel Dekker, New York (1983)
  46. R. L. Bronaugh and H. I. Maibch, J. Investigative Dermatology, 84, 180 (1985a) https://doi.org/10.1111/1523-1747.ep12264716
  47. R. L. Bronaugh and H. I. Maibach, Percutaneous Penetration, Marcel Dekker, London (1985b)
  48. D. R. Friend, Journal of Controlled Release, 18, 235 (1992) https://doi.org/10.1016/0168-3659(92)90169-R
  49. M. J. Bartek, J. A. LaBudde, and H. I. Maibach, J. Investigative Dermatology, 58, 114 (1972) https://doi.org/10.1111/1523-1747.ep12538909
  50. F. N. Marzulli and H. I. Maibach, Relevance of Animal Models: the Hexachlorophene Story, ed. H. I. Maibach, Animal Models in Dermatology, Churchill-Livingstone, Edinburgh (1975)
  51. M. E. Roberts and K. R. Mueller, Pharmaceutical Research, 7, 673 (1990) https://doi.org/10.1023/A:1015842916969
  52. K. Harada, T. Murakami, E. Kawasaki, Y. Hagashi, S. Yamamoto, and N. Yata, J. Pharmacy and Pharmacology, 45, 414 (1993) https://doi.org/10.1111/j.2042-7158.1993.tb05567.x
  53. T. Pongjanyakul, S. Prakongpan, S. Panomsuk, S. Puttipipathkhachorn, and A. Priprem, J. Pharmacy and Pharmacology, 54, 1345 (2002) https://doi.org/10.1211/002235702760345419
  54. G. P. Moss, J. C. Dearden, H. Patel, and M. T. Cronin, Toxicology in vitro, 16, 299 (2002) https://doi.org/10.1016/S0887-2333(02)00003-6
  55. W. G. Reinfenrath, E. M. Chellquist, E. A. Shipwash, W. W. Jederberg, and G. G. Krueger, British J. Dermatology, 111, 123 (1984)